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Nolz1 expression is required in dopaminergic axon
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Midbrain dopaminergic (DA) axons make long longitudinal projections towards the striatum.
Despite the importance of DA striatal innervation, processes involved in establishment of DA
axonal connectivity remain largely unknown. Here we demonstrate a striatal-specific
requirement of transcriptional regulator Nolz1 in establishing DA circuitry formation. DA
projections are misguided and fail to innervate the striatum in both constitutive and striatal-
specific Nolz1mutant embryos. The lack of striatal Nolz1 expression results in nigral to pallidal
lineage conversion of striatal projection neuron subtypes. This lineage switch alters the
composition of secreted factors influencing DA axonal tract formation and renders the
striatum non-permissive for dopaminergic and other forebrain tracts. Furthermore, tran-
scriptomic analysis of wild-type and Nolz1−/−mutant striatal tissue led to the identification of
several secreted factors that underlie the observed guidance defects and proteins that pro-
mote DA axonal outgrowth. Together, our data demonstrate the involvement of the striatum
in orchestrating dopaminergic circuitry formation.
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M idbrain dopaminergic (DA) neurons play an importantrole in several brain functions including locomotion,motivation and reward processes1. The guidance of DA
axons towards their target areas is an important step in the
establishment of functional circuits that are required for execut-
ing those roles. The projections of several molecularly distinct
subpopulations of DA neurons have been defined2–4 with sub-
stantia nigra (SN) and VTA DA neurons innervating the dorsal
and ventral part of the striatum respectively, consistent with their
specific roles. While the specification of DA neurons and their
projection areas have been intensively studied, it remains rela-
tively unclear how the establishment of DA axonal projections
and striatal innervation are regulated during embryonic
development.
After exiting the midbrain DA axons are attracted by and
fasciculated within the medial forebrain bundle (MFB)5, which
forms two rostrally oriented ipsilateral tracts within the ventral
diencephalon. These axonal tracts run parallel to the ventral
midline towards target areas in the forebrain including the
striatum and cortex6. Several secreted guidance molecules with
either attractive or repulsive activities are involved in the
navigation of DA axons towards their target areas, including
Slit/Robo, Netrin/Dcc, Ephrin, Semaphorin and Wnt signalling
components7. Besides extrinsic factors secreted in the envir-
onment, axons can also be guided to the target areas by reci-
procal axon–axon interactions as demonstrated for the
innervation of the lateral habenula8 and the establishment of
thalamocortical–corticothalamic interactions9. However, whe-
ther establishment of DA connectivity is influenced by striatal
patterning or the formation of striatal axonal extensions has not
been determined.
The majority of the neurons in striatum are projection neu-
rons, which can be subdivided into two subpopulations based on
their transcriptional profile and target innervation10–12. Striato-
nigral projection neurons are specified by several transcription
factors including Isl1, Ebf1 and Rarb and directly innervate the
SN13–17. In contrast, striatopallidal neurons project to the GP and
give rise to the indirect pathway. Here we investigate whether and
how striatal patterning influences the guidance and target
innervation of DA axons.
Nolz1 is as a transcriptional regulator expressed in the VTA
DA neuronal lineage and striatal projection neurons18–21. Here
we show that in the absence of striatal Nolz1 expression DA
axons are misguided and fail to innervate the striatum. We
demonstrate that the striatonigral to -pallidal switch in projection
neuron subtype identity in Nolz1−/− mutant embryos is asso-
ciated with defects in establishment of DA and forebrain axonal
tracts. The altered composition of guidance factors secreted from
Nolz1−/− mutant striatum provide a non-permissive environ-
ment for DA axons and other forebrain axonal tracts. Tran-
scriptomic analysis resulted in the identification of proteins that
can rescue the defects in DA axonal outgrowth. Finally, the
acquired insight into mechanisms involved in DA circuitry for-
mation will facilitate the development of approaches to improve
graft outcome in cell transplantation studies.
Results
Nolz1 is required for establishment DA axonal connectivity.
Previously, we have shown that Nolz1 is expressed in the VTA
DA neuronal lineage18. To investigate the role of Nolz1 in DA
neuron development, we analyzed tyrosine hydroxylase (TH)
expression by iDISCO22 in E18.5 Nolz1−/− mutant embryos, in
which the coding region of Nolz1 has been replaced by beta-
Galactosidase (also referred to as Nolz1bgal/bgal) (Supplementary
Fig. 1a). IDISCO analysis revealed that DA axons are misguided
in Nolz1−/− mutant embryos (Fig. 1a–d). While in wild-type
embryos DA axons extend rostrally through the hypothalamus
and innervate the striatum at E18.5 (Fig. 1a, c), a large proportion
of TH labelled axons cross the midline in the hypothalamus
(arrows in Fig. 1b, d) and terminate rostral of the striatum
(arrowheads in Fig. 1b, d) in the mutant embryos. Analysis of
NOLZ1 expression in relation to DA axons labelled by GlycoDAT
and TH shows that NOLZ1 is expressed in regions that display
the guidance phenotype e.g. the hypothalamus (arrow Fig. 1e, q,
s) and striatum (arrowhead Fig. 1g, i)19–21. It further confirmed
that a subset of DA axons cross the midline (Fig. 1e, f, k, l, q, r)
and the remaining axons terminate rostral of the striatum (Fig. 1i,
j, u, v) resulting in a lack of innervation of the rostral areas
(Fig. 1g, h, m, n).
To investigate whether the DA axons that cross the midline
have a different identity in comparison with the axons that keep
following their trajectory towards the striatum, we analyzed the
expression of GlycoDAT, which is higher expressed in SN
neurons and their projections compared with VTA neurons23.
Interestingly, mainly GlycoDAT+TH+ SN DA axon bundles
crosses the midline (Fig. 1k, l), while GlycoDAT−TH+ axons
extend towards the striatum (Fig. 1m, n), indicating that SN and
VTA derived DA axons respond differentially to the absence of
Nolz1 expression. Furthermore, the DA axon bundle is
defasciculated and more spread out along the medial–lateral axis
in Nolz1−/− mutant embryos (Fig. 1o, p). Other axonal tracts
running in the MFB are also misguided with 5HT labelled
serotonergic axons crossing the midline alongside DA axons
(Supplementary Fig. 1b).
While the caudal part of the striatum remains innervated to a
certain extent, the globus pallidum (GP) is totally devoid of any
DA terminals in Nolz1−/− mutant embryos (Fig. 1i, j, w, x and
Supplementary Fig. 2a). The GP specification is normal as shown
by CTIP2 (Fig. 2h, j) and NKX2.1 (Supplementary Fig. 2b)
expression in Nolz1−/−mutant embryos. However, in the absence
of Nolz1 we observed several aberrantly located ISL1+ positive
cells (Supplementary Fig. 2c) within in the GP, which could
underlie the defect in striatal innervation by DA axons24.
Finally, the axon guidance phenotype observed in embryos
lacking Nolz1 expression was not caused by the mislocalization or
elimination of mutant cells as bGAL expression in Nolz1bGal/bGal
mutant embryos was similar to Wt and heterozygous embryos in
the midbrain (Supplementary Fig. 1c), hypothalamus (Fig. 1q–t
(arrows)) and the striatum (Figs. 1u–x, 2w).
Nolz1 is required for striatal projection neuron development.
The DA axon guidance phenotype observed in Nolz1−/− mutant
embryos could not be explained by defects in DA neuron differ-
entiation or hypothalamic patterning as no striking changes in DA
neuron and hypothalamic marker expression could be observed
(Supplementary Figs. 1c–e, 3a, b and Supplementary Table 1).
However, we found that Nolz1 is required for the specification of
striatal projection neurons. NOLZ1 is expressed by all striatal
projection neurons as demonstrated by its overlap with DARPP32
(Fig. 2a, a′) and CTIP2 (Fig. 2g, g′) expression20,21. In Nolz1bgal/bgal
mutant embryos striatal projection neurons, labelled by CTIP2
and bGAL, lack DARPP32, indicating that there is a defect in
their maturation (Fig. 2b, b′, d, d′). DARPP32 expression appears
in clusters in Nolz1−/− mutant striatum that are positively
labelled by L1 (Fig. 2f), indicating that these clusters represent
abnormally fasciculated axonal tracts. There was a loss of SN
innervation by DARPP32+ labelled striatal projection neurons in
Nolz1−/− mutant embryos (Fig. 2q–t). In contrast, the expression
of CTIP225 (Fig. 2g, g′, i, i′, w) was unchanged in Nolz1bgal/bgal
mutant, suggesting that the differentiation of striatal projection
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Fig. 1 Nolz1−/− mutant embryos display DA axon guidance defects. a–d Visualization of TH+ DA axon bundles in E18.5 Wt and Nolz1−/− mutant mouse
brains stained and cleared according to the iDISCO protocol. a Arrow point to DA axon bundle running in parallel to the ventral midline. b, d Arrows
indicate midline crossing of DA axon bundle in Nolz1−/− mutant embryos. b Arrowhead points to axons terminating in front of the striatum. c Arrowhead
points to normal DA innervation of striatum in Wt embryos, which is disrupted Nolz1−/− mutant embryos (arrowhead in d). Sagittal view in a, b and ventral
view in c, d. e–j Immunohistochemical analysis of GlycoDAT and NOLZ1 expression in the hypothalamus (e, f) and striatum (g–j) of E18.5 mouse Wt and
Nolz1−/−mutant embryo. Arrows indicate midline crossing of DA axon bundles in the Nolz1−/−mutant hypothalamus (f). i, j Arrows point to the GP, which
lacks innervation in Nolz1−/− mutant embryos. Arrowheads pointing to NOLZ1 positive cells in the hypothalamus (e) and striatum (g, i) of Wt embryos.
k–p Immunostaining showing expression of GlycoDAT and TH in the hypothalamus (k–l), striatum (m–n) and caudal diencephalon/midbrain (o–p) in E18.5
Wt and Nolz1−/− mutant embryos. Arrow in (l) indicates GlycoDAT+ TH+ DA axons crossing the midline in Nolz1−/− mutant hypothalamus. o, p Dashed
line indicates the width of the DA axon bundle extending from Nolz1−/− mutant midbrain. q–x Expression of GlycoDAT and NOLZ1/BGAL in the
diencephalon (q–t) and striatum (u–x) of Wt and Nolz1−/− mutant embryos. Arrows indicating NOLZ1+BGAL+ labelled cells in Nolz1bgal/+ heterozygous
(q, q′, s) and bGAL labelled cells in Nolz1bGal/bGal homozygous mutant (r, r′, t) hypothalamus. u, v DA axon bundles terminate in front of striatum in
Nolz1bGal/bGal mutant embryos. w, x GP in Nolz1bGal/bGal mutant embryos is devoid of BGAL labelled cells and lack innervation by DA terminals. q, r, u, v
sagittal and s, t, w, x coronal view. Data are representative of two (a–d) or three (e–x) independent experiments. Mb (midbrain), Str (striatum), GP (globus
pallidus), Zi (Zona Incerta), Hth (hypothalamus). Scale bar 1000 μm (a–d); 200 μm (e–x).
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neurons was normally initiated. In addition, striatal projection
neuron markers FOXP1 and FOXP226,27 were downregulated in
Nolz1−/− mutant striatum (Fig. 2k–n, w). There was no change in
cell number, striatal volume and number of bGAL labelled cells
between Nolz1bGal/+ and Nolz1bGal/bGal mutant striatum (Fig. 2u,
v, w). Consistently, there was no increase in apoptosis in the
absence of striatal Nolz1 expression (Supplementary Fig. 2d).
These data show that striatal Nolz1 expression is required for the
generation of mature striatal projection neurons and their pro-
jections towards the midbrain.
Differential effect of striatal genes in the absence of Nolz1. To
gain further insight into the transcriptomic changes that underlie
the phenotypic alteration in Nolz1−/− mutant striatum we
compared the gene expression profile of E18.5 wild-type with
Nolz1−/− mutant striatum using RNA sequencing (Fig. 3a). The
differentially expressed genes (Supplementary data 1) were sub-
jected to hierarchical clustering and displayed in a heatmap,
which revealed clusters of genes that were either higher (yellow)
or lower (blue) expressed in the wild-type compared with mutant
striatum (Fig. 3b). The transcriptomic data confirmed the
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downregulation of generic striatal projection neuron markers
DARPP32, FOXP1 and FOXP2 as observed in Nolz1−/− mutant
embryos (Fig. 3f and Supplementary data 1). Interestingly, ana-
lysis of the genes representing the different clusters revealed that
several genes downregulated in Nolz1−/− mutant embryos
(clusters 1, 2, 5b and 5c) are selectively expressed in striatonigral
projection neurons, while striatopallidal neuron specific genes
were expressed higher in the mutant (clusters 3, 4, 5a and 5e)10–12.
We at randomly selected 61 differentially expressed genes for
further verification and we could validate the expression of 67%
of these genes (Supplementary data 2). The striatonigral specific
genes, including Drd1, Rarb, Ebf111, Isl1, Zfp521, Tac1 and Pdyn
were either downregulated or absent in the E15.5 Nolz1−/−
mutant striatum (Fig. 3d, f). In addition, striatopallidal neuron
specific genes Drd2, Six3, Grg4 (Tle4), Grik3, Penk, Ptprm and
Adora2a were upregulated in the mutant striatum, except for
Gpr6 (Fig. 3e, f). Despite the upregulation of several pallidal
markers, the projections of striatopallidal neurons towards the GP
were impaired in Nolz1−/− mutant embryos as revealed by the
analysis of PENK (Supplementary Fig. S2e). Genes involved in
early striatal patterning, progenitor-, glial- and interneuron spe-
cification were not changed in Nolz1−/− mutant striatum (Sup-
plementary data 1). Thus, Nolz1 is selectively required for the
specification of striatonigral projection neurons and in the
absence of Nolz1 expression several striatopallidal markers are
ectopically expressed in the striatum.
Striatonigral to pallidal switch in Nolz1−/− mutant striatum.
Next, we investigated the specification of the striatal projection
neuron subtypes in Nolz1−/− mutant embryos in more detail. In
E18.5 Nolz1bgal/+ heterozygous mutant embryos about 40% of the
striatal projection neurons labelled by bGAL express the striato-
pallidal marker SIX3 (Fig. 4c), which is expanded to nearly all
(90%) striatal projection neurons in Nolz1bgal/bgal mutant embryos
(Fig. 4c). Since there is no reduction in total number of striatal
projection neurons (Fig. 2v, w), the striatopallidal selective genes
are most likely upregulated at the expense of nigral-specific
markers in Nolz1−/− mutant embryos. The temporal analysis of
striatonigral and pallidal markers at several embryonic stages
shows that the nigral to pallidal switch occurs at the time pro-
jection neurons are born. The striatopallidal lineage specific
markers Six3, Grg4 and Drd2 are upregulated in Nolz1−/− mutant
embryos compared with Wt embryos at E11.5 and E12.5 (Fig. 4a,
b). Immunolabelling shows that SIX3 is expressed in all bGAL
labelled striatal projection neurons in E11.5 Nolz1bgal/bgal mutant
embryos, while the expression of striatonigral specific marker
EBF1 (Fig. 4a, b) is not induced at any examined stage. Together,
the temporal expression analysis demonstrates that the striatoni-
gral to pallidal lineage switch in Nolz1−/− mutant embryos
coincides with the timing of striatal projection neuron production.
During striatal development the timing of cell cycle exit
contributes to the subtype identity of striatal projection neu-
rons28–30 and the majority of neurons born at E11.5 have
striatonigral specific identities with the number of striatopallidal
neurons increasing over time29,31,32. To analyse whether altered
timing of striatal projection neuron production contributes to the
fate change in Nolz1−/− mutant embryos we administered
Bromodeoxyuridine (BrdU) to pregnant females at E10.5, E11.5
or E12.5 and analyzed the embryos at E15.5. While the percentage
of BrdU labelled striatal neurons increases between E10.5 and E12.5
in Wt embryos, significantly less neurons were born in E11.5
Nolz1−/− mutant striatum (5% in mutants vs. 20% in wild-type)
(Fig. 4d and Supplementary Fig. 4e). No differences in BrdU
labelling between Wt and mutant embryos were observed when
BrdU was injected at E10.5 or E12.5 (Fig. 4d and Supplementary
Fig. 4e). The majority of the neurons labelled by BrdU resulting
from injections at E11.5 and E12.5 expresses FOXP1 (Fig. 4e, f),
indicating that mainly projection neurons are born at these stages
in both Wt and Nolz1−/− mutant embryos. The reduced levels of
BrdU labelling at E11.5 in Nolz1−/− mutant embryos coincide with
the timepoint when the majority of neurons born in Wt embryos
are positive for the striatonigral specific marker EBF111 (Supple-
mentary Fig. 4a–c) and is consistent with the absence of
striatonigral neurons in Nolz1−/− mutant embryos. In contrast to
the Wt striatum, the majority of BrdU labelled neurons in
Nolz1−/− mutant striatum expresses the pallidal marker SIX3
(Supplementary Fig. 4f, g). This further demonstrates that neurons
born between E10.5 and E12.5 have already been directed towards
the striatopallidal fate. Furthermore, there is a strong reduction of
the striosomal marker MOR1 (Supplementary Fig. 4h) and an
expansion of the matrix marker CALBINDIN1 (Supplementary
Fig. 4i) in Nolz1−/− mutant striatum, which is in line with the loss
of early born neurons30,32. No changes in BrdU labelling was
observed in the cortex (Supplementary Fig. 4d, e). The absence of
Nolz1 in the ventricular zone and in proliferating cells within the
subventricular zone21 (Supplementary Fig. 4j), suggests that Nolz1
regulates the temporal production of striatal projection neurons
non-cell-autonomously through a yet unknown mechanism.
Striatal selective requirement Nolz1 in DA axon guidance. To
investigate in which brain region Nolz1 function is required for
guiding DA axons to the striatum in more detail, we crossed
Fig. 2 Striatal projection neurons fail to develop in Nolz1−/− mutant embryos. a–b Immunostaining showing DARPP32 and NOLZ1/BGAL expression in
the striatum of E18.5 Nolz1bgal/+ and Nolz1bgal/bgal mutant embryos. c–d Immunohistochemical analysis of CTIP2 and DARPP32 staining in Nolz1bgal/+ and
Nolz1bgal/bgal mutant striatum at E18.5. e–f DARPP32/L1 staining in the striatum of E18.5 Nolz1bgal/+ and Nolz1bgal/bgal mutant embryos indicate abnormal
overlap between L1 and DARPP32 in Nolz1bgal/bgal mutant striatum. g–j CTIP2 and NOLZ1/BGAL expression in the rostral (g, i) and caudal (h, j) striatum of
E18.5 Nolz1bgal/+ and Nolz1bgal/bgal mutant embryos. Note the absence of NOLZ1/BGAL in the GP of Nolz1bgal/+ (h, h′) and Nolz1bgal/bgal (j, j′) mutant
embryos. k–l Immunofluorescence analysis of FOXP1 in the striatum of E18.5 Wt and Nolz1−/− mutant striatum. m–n Immunostaining showing FOXP2
expression in E18.5 Wt and Nolz1−/− mutant striatum. o–t Immunohistochemical analysis of GlycoDAT and DARPP32 expression in E18.5 Wt and Nolz1−/−
mutant embryos. (o, p) Sagittal sections of striatum showing reduced levels of DARPP32 and GlycoDAT labelled DA terminals in Nolz1−/− mutant
embryos. (q–r) Sagittal sections of the midbrain/diencephalon. Arrow in (r) indicates the absence of DARPP32+ striatal axons projecting towards the
midbrain in mutant embryos. s–t coronal sections of the midbrain/diencephalon. t Arrow indicates the absence of DARPP32+ striatal axons innervating DA
neurons in midbrain in Nolz1−/− mutant embryos. u Graph shows the relative difference of the striatal area (mm2) between E15.5 Wt and Nolz1−/− mutant
embryos (n= 3 biologically independent samples). Wt values are normalized to 100%. Mean values ± standard deviation. v Graph shows the relative
difference in DAPI+ cell number between E15.5 Wt and Nolz1−/− mutant striatum. (n= 3 biologically independent samples). Wt values are normalized to
100%. Mean values ± standard deviation. w Graph indicates the percentage of FOXP1+, CTIP2+ and bGAL+ cells against the total number of DAPI+ cells
(n= 3 biologically independent samples) in the striatum of E18.5 Wt and Nolz1−/− mutant embryos. Mean values ± standard deviation. Two-sided,
unpaired T-test ***p= 1.86067xE−06. Data are representative of three independent experiments (a–t). Scale bar: 200 μm (a–r), 500 μm (s–t). Source data
are provided as a source data file.
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Fig. 3 Striatonigral to -pallidal switch of projection neuron identity in Nolz1−/− mutant striatum. a Schematic outline of dissection followed by RNA
sequencing analysis of Wt and Nolz1−/− mutant striatal tissue. b Heatmap showing differentially expressed genes in the E18.5 Wt and Nolz1−/− mutant
striatum (n= 3 biologically independent samples). Upregulated genes are shown in yellow and downregulated genes in blue. Hierarchical clustering
indicates that clusters 1, 2, 5b and 5c represents striatonigral and clusters 3, 4, 5a and 5e striatopallidal selective genes. c Schematic representation of
section plane used to obtain coronal sections through the striatum of E15.5 embryos. d–e Analysis of differentially expressed genes in E15.5 Wt and
Nolz1−/− mutant striatum by in situ hybridization validating the transcriptomic analysis. Striatonigral markers are downregulated (d) and several
striatopallidal-specific markers are upregulated in Nolz1−/− mutant striatum (e). f A selection of striatopallidal, striatonigral and generic projection neurons
markers that are differentially expressed between Wt and Nolz1−/− mutant striatum as identified by RNA sequencing. Graph represents fold change gene
expression values in Nolz1−/− mutant striatum relative to Wt (n= 3 biologically independent samples). Expression values are presented as mean ±
standard error log2 transformed values. g Expression validation by in situ hybridization of identified axon guidance molecules in E15.5 Wt and Nolz1−/−
mutant striatum. Data are representative of three independent experiments (d, e, g). Scale bar (d, e, g): 200 μm. str (striatum), cx (cortex). Source data are
provided as a source data file.
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Nolz1fl/fl conditional mouse line with the midbrain (En1Cre),
hypothalamic (FoxD1Cre) and telencephalic (FoxG1-IRES-Cre)
specific Cre lines33–35 (Fig. 5a). Nolz1 was selectively ablated from
the different regions using the respective Cre lines at E11.5 (Sup-
plementary Fig. 5a). While no phenotypic alteration are observed
in E18.5 control embryos (Cre+, Nolz1fl/fl or Cre+; Nolz1fl/+)
(Fig. 5b–b′′), the selective ablation of Nolz1 in the striatum of
FoxG1-IRES-Cre;Nolz1fl/fl mutant embryos (Fig. 5c–c′′) resulted in
a DA axon defect highly similar to the phenotype observed in the
constitutive Nolz1−/− mutant embryos. There was a strong
reduction in striatal innervation by DA terminals (Fig. 5c, g) and
a subset of DA axon bundles crossed the midline (Fig. 5c′),
although to a lesser extent compared with Nolz1−/− mutant
embryos. In contrast, the deletion of Nolz1 in either the hypo-
thalamus (FoxD1Cre;Nolz1fl/fl) (Fig. 5d–d′′ and Supplementary
Fig. 5g) or midbrain (En1Cre;Nolz1fl/fl) (Fig. 5e–e′′ and Supple-
mentary Fig. 5g, h) did not affect the guidance of DA axons
towards the striatum or striatal innervation (Fig. 5g), demon-
strating the striatal-specific requirement of Nolz1 expression for
establishing the DA circuitry. Furthermore, FoxG1-IRES-Cre;
Nolz1fl/fl mutant embryos displayed similar phenotypic altera-
tions as observed in Nolz1−/− mutant embryos, including the
striatonigral to -pallidal fate change (Fig. 5h), altered expression
of striatal axon guidance markers (Fig. 5i), the absence of
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DARPP32 expression (Fig. 5j, k), lack of innervation of the GP
(Supplementary Fig. 2a) and cCASP3 expression around the GP
(Supplementary Fig. 2d). In contrast, there were no gene
expression changes observed in the EnCre;Nolz1fl/fl mutant
striatum (Supplementary Fig. 5i). Furthermore, the innervation of
the prefrontal cortex was normally initiated in E18.5 EnCre;
Nolz1fl/fl mutant embryos, while the fibre density of the nucleus
accumbens was not changed in adults (Supplementary Fig. 5d–f).
Despite, the striatal selective ablation of Nolz1, born Foxg1-IRES-
Cre;Nolz1fl/fl mutant pups died within 1 month after birth for
unknown reasons.
Nolz1 regulates establishment of axonal forebrain tracts. The
striatum is important for the establishment of several other
forebrain axonal tracts, including thalamocortical and
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corticothalamic projections36–39. Therefore, we investigated
whether striatal absence of Nolz1 causes misrouting of other
axonal tracts. Both Neurofilament (NF) and L1 cell adhesion
molecule (L1) labelled axonal tracts are disorganized and fasci-
culate abnormally in Nolz1−/− and FoxG1-IRES-Cre;Nolz1fl/fl
striatum of E15.5 and E18.5 mutant embryos (Supplementary
Fig. 6a–i). In addition, L1 labelling shows that thalamocortical
axons are normally formed in Nolz1−/− mutant embryos (Sup-
plementary Fig. 6p, q), but fail to extend into the striatum
(Supplementary Fig. 6j, l). In addition, DiI injected in the thala-
mus further reveals that thalamic axonal extension project ven-
trally instead of projecting towards the striatum in Nolz1−/−
mutant embryos (Supplementary Fig. 8d). Within the thalamic
region we observe a strong increase in cCASP3 expression in L1
labelled thalamic axons that project towards the striatum in Nolz1
−/− mutant embryos at E18.5 (Supplementary Fig. 6m–p), but
not in other axonal populations (Supplementary Fig. 6o, p).
FoxG1-IRES-Cre;Nolz1fl/fl mutant embryos, which have a similar
axon guidance phenotype, only show a minor induction of
cCASP3 in the thalamic region (Supplementary Fig. 6r, s).
Overlap between cCASP3 and bGAL expression in Nolz1−/−
mutant cells (Supplementary Fig. 6q) indicate a cell-autonomous
role of Nolz1 in regulating apoptotic marker expression. The
phenotypic resemblance between the constitutive and conditional
striatal-specific Nolz1 mutant mouse lines demonstrates striatal,
non-cell-autonomous requirement of Nolz1 in orchestrating the
attraction and guidance of DA and other axonal tracts through
the striatum.
Defects in formation of striatal axonal extensions has been
linked to abnormalities in forebrain axonal tract formation36. To
investigate whether the striatal outgrowth is affected in Nolz1−/−
mutant embryos we injected DiI in E15.5 wild-type and mutant
striatum (Fig. 6a–d). DiI injected in the wild-type striatum was
retrogradely transported to the midbrain in Wt embryos (Fig. 6a,
b), but not in Nolz1−/− mutant embryos (Fig. 6c, d) revealing a
defect in the establishment of striatonigral projections (Fig. 6c).
Consistent with the absence of striatonigral projections, the
axonal length in striatal explants from Nolz1−/− mutant embryos
was significantly shorter compared with wild-type explants
(Fig. 6e, f).
Nolz1−/− mutant striatum secretes cues repulsive to DA axons.
Next we investigated whether either reduced striatal axonal out-
growth or altered guidance cue expression could underlie the
defects in establishment of DA neuronal connectivity observed in
Nolz1−/− mutant embryos. In the absence of Pcdh10 striatal
axonal extensions failed to form36, a phenotype similar to that
observed in Nolz1−/− mutant embryos. The lack of striatal axonal
outgrowth in Pcdh10−/− mutant embryos caused defects in the
formation thalamocortical projections as shown by L1 and NF
labelling (Supplementary Fig. 7b, c)36. Furthermore, Darpp32
expressing striatonigral axons failed to outgrow towards the
midbrain (Fig. 6g, h)36. Despite the reduced striatal axonal out-
growth, the innervation of the striatum by DA axon terminals was
not affected (Fig. 6i, j) in E14.5 mutant embryos. Furthermore, in
Pcdh10−/− mutant embryos both striatonigral and -pallidal
projection neurons markers and genes involved in axon guidance
are normally expressed (Supplementary Fig. 7a). Thus the lack of
striatal outgrowth alone does not cause the aberrant DA axonal
trajectory observed in Nolz1−/− mutant embryos.
The transcriptomic analysis revealed that a subset of genes
involved in axon guidance were altered in Nolz1−/− mutant
striatum, including Netrin1, Sema3a, Vegfc, PlxnD1 and Tgfa
(Fig. 3g, Supplementary Fig. 3a, Supplementary Table S2 and
Supplementary data 1). Therefore, we investigated whether the
altered composition of secreted factors from the striatum
influences the guidance of DA axons towards the striatum. There
was no difference in axonal length and direction of outgrowth
between wild-type and Nolz1−/− mutant ventral midbrain
explants when cultured alone (Supplementary Fig. 8a). DA axons
labelled by B-TUBULIN and TH extended from wild-type and
Nolz1−/− mutant midbrain explants were attracted by wild-type
striatal explants40 (Fig. 6k–m; P/D ratio > 1). However, when
midbrain explants were cocultured with Nolz1−/− mutant striatal
explants DA axons were strongly repelled40 (Fig. 6k–m; P/D ratio
< 1). The distance between the explants was equal under all
conditions (Fig. 6n). Similarly, axonal extension emanating from
the thalamus were repulsed by striatal explants obtained from
Nolz1−/− mutant embryos (Supplementary Fig. 8b, c). In contrast
to midbrain explants, Nolz1−/− mutant thalamic explants were
also repulsed by wild-type striatal explants indicating a thalamic
requirement of Nolz1 in mediating chemoattraction.
The explant cocultures suggest that secreted factors emanated
by Nolz1−/− mutant striatum5 exerts a repulsive effect on DA
axons. In agreement, conditioned medium collected from
cultured Nolz1−/− mutant striatal explants caused collapsed
growth cones on nearly 70% of the axons derived from ventral
midbrain explants (Fig. 7a, b)41, showing that factors secreted
from the mutant striatum repulse DA axon outgrowth. Condi-
tioned medium from Wt striatal explants did not have any effect
on the growth cone morphology (Fig. 7a, b; 24% vs. 20% in
controls). Of the secreted factors differentially expressed between
wild-type and Nolz1−/− mutant striatum (Fig. 3g) we found that
SEMA3A caused more than 70% of the growth cones to collapse,
while TGFA and NETRIN1 did not have any effect (Fig. 7a, b).
To investigate further whether there is a difference in the
potential to attract DA axons over longer distances between wild-
Fig. 5 DA axon guidance phenotype is mediated by lack of striatal Nolz1 expression. a Schematic representation of conditional Nolz1 locus and Cre
deleter lines used to ablate Nolz1 in the following regions: En1Cre for midbrain, FoxD1Cre for hypothalamic and FoxG1-IRES-Cre line for telencephalic selective
recombination. b–e Immunostaining for NOLZ1 and GlycoDAT on coronal sections of E18.5 mouse striatum, hypothalamus and midbrain in the following
mouse lines: Control (b–b′′), FoxG1-IRES-Cre;Nolz1 fl/fl (c–c′′), Foxd1Cre;Nolz1 fl/fl (d–d′′) and En1Cre;Nolz1 fl/fl (e–e′′) mutant embryos. Arrow in c′ points to
DA axon bundles crossing the midline. f Representative outline of coronal sections from E18.5 mouse striatum (top), hypothalamus (middle) and midbrain
(bottom) indicating regions represented in b–e. Cx (cortex), Str (striatum), MFB (medial forebrain bundle), SN (substantia nigra). g Graph showing
GlycoDAT fibre density in the striatum of E18.5 Nolz1−/−, FoxG1-IRES-Cre;Nolz1 fl/fl, FoxD1Cre;Nolz1 fl/fl and En1Cre;Nolz1 fl/fl mutant embryos relative to Wt
embryos (n= 3 biologically independent samples). Wt values are normalized to 100%. Mean values ± standard deviation. Wt versus Nolz1−/−: Two-sided,
unpaired T-test ***p= 0.00098. Wt versus FoxG1-IRES-Cre;Nolz1 fl/fl: Two-sided, unpaired T-test **p= 0.00605. h Analysis of striatonigral and
striatopallidal-specific markers in control and FoxG1-IRES-Cre;Nolz1 fl/fl mutant embryos by in situ hybridization. Coronal striatal sections of E15.5 embryos.
i Downregulation of axon guidance markers in E15.5 in FoxG1-IRES-Cre;Nolz1 fl/fl mutant embryos as shown by in situ hybridization on coronal sections. j–k
Reduction of DARPP32 expression and innervation by GlycoDAT labelled axons in the striatum of E18.5 FoxG1-IRES-Cre Nolz1 fl/fl mutant embryos visualized
by immunohistochemistry on coronal sections. Data are representative of three independent experiments (b–e, h–k). Scale bar (b–k): 200 μm. Source data
are provided as a source data file.
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outgrowth from mES cell derived DA neurons (Supplementary
Fig. 8f). However, the axonal attraction mediated by wild-type
striatal tissue was totally abolished in the presence of the ERBB
inhibitor Afatinib43 (Fig. 7i, j and Supplementary Fig. 8e). These
data demonstrate that TGFA signalling activation is sufficient to
attract DA axonal projections.
Discussion
The correct establishment and maintenance of DA axonal pro-
jections is important for normal brain function and defects in
these processes underlie neurological and neurodegenerative
diseases including Schizophrenia and Parkinson’s disease44,45.
Here we showed how striatal patterning defects in Nolz1−/−
mutant embryos have an impact on the establishment of DA
axonal projections, which led us to propose the following model
as depicted in Fig. 8. (1) In both constitutive and striatal-specific
conditional Nolz1 mutant embryos a subset of DA axons crosses
the ventral midline in the hypothalamus. The remaining axons
maintain their trajectory towards rostral brain areas, but termi-
nate in front of the striatum. (2) Furthermore, in the absence of
striatal Nolz1 expression striatopallidal projections neurons are
produced at the expense of striatonigral neurons. This lineage
switch resulted in reduced striatal outgrowth (3) and altered
composition of growth factors secreted from the striatum (4). The
guidance of DA axons towards target areas does not depend on
the elongation of striatal axons (3). Instead, the impaired striatal
projection neuron specification and striatonigral–pallidal subtype
conversion create a repulsive environment for DA growth cones
and other forebrain tracts (4). Thus, we demonstrated that defects
in striatal projection neuron specification have a direct effect on
DA axonal tract formation and striatal innervation.
We showed that Nolz1, which is expressed in all striatal pro-
jection neurons, is selectively required for the specification of
striatonigral projection neurons. In Nolz1−/− mutant embryos the
expression of several striatonigral specific genes are either reduced
or absent, which is accompanied by the ectopic induction of
striatopallidal-specific genes. Nolz1 acts upstream of several other
transcription factors that have been previously implicated in
regulating the striatonigral fate. However, the striatonigral selec-
tive transcriptional regulators Isl1, Ebf1, Foxo1 and Rarb13–17,46,
regulate only a subset of striatonigral specific genes resulting in a
much milder striatal phenotype. Although most of the striato-
pallidal markers are normally induced in the Nolz1−/− mutant
striatum, the pallidal fate is not fully executed as shown by the
reduction of Darpp32, Arpp21 and Gpr6 expression and the
reduced innervation of the GP by striatopallidal neurons. Thus,
while mainly the generation of striatonigral neurons is affected in
the absence of striatal Nolz1 expression, Nolz1 might also be
required to regulate certain aspects of the striatopallidal fate. We
found that in the absence of striatal Nolz1 expression, striato-
pallidal projection neurons are generated at the expense of
striatonigral neurons. As a transcriptional repressor19,47–49 Nolz1
might promote the specification of nigral neurons by directly
repressing striatopallidal-specific genes. A partial nigral to pallidal
lineage switch is also observed in Isl1−/− mutant embryos15 and
Nolz1 might interact with Isl1 to prevent that pallidal tran-
scriptional programmes are unsilenced in nigral neurons. The
downregulation of striatonigral specific genes in the Nolz1
mutant striatum might be a consequence of the upregulated
expression of pallidal genes in nigral neurons. Candidates for
mediating the repression of nigral-specific gene programmes are
Six3 and Tle450,51. Both genes are transcriptional repressors that
have been previously implicated in pallidal fate specification52
and are ectopically expressed in Nolz1−/− mutant striatum. In
contrast to Nolz1 and Isl1, which are involved in the repression of
pallidal genes, histone methyltransferase G9a is required to pre-
vent the ectopic induction of striatonigral specific genes53. Thus,
the specification of these two distinct projection neuron subtypes
is at least to some extent dependent on the repressing activities of
nigral and pallidal lineage determining factors. Our data also
revealed that Nolz1 is involved in the timing of striatal projection
neuron production, which could influence the subtype identity as
well. BrdU birthdating experiments showed a strong decrease in
neuronal birth at E11.5 in Nolz1−/− mutant embryos, which
coincides with the production of EBF1 positive striatal projection
neurons. Since Nolz1 expression is restricted to post-mitotic
neurons, it is not clear how Nolz1 regulates cell cycle exit in the
ventricular zone. A possibility is that Nolz1 influence the tem-
poral aspects of projection neuron production indirectly through
the induction of other secreted factors.
DA axons are guided to their target areas by temporal and
spatial exposure to repulsive and attractive cues. Explant studies
have revealed that DA axons are initially attracted by the MFB,
followed by the striatum at later stages5,54. The initial recruitment
of DA axons towards the MFB is not affected in Nolz1−/− mutant
embryos. However, the subsequent progression of DA axonal
projections into a rostral direction towards the striatum is dis-
rupted, resulting in midline crossing of a subset of DA axons and
lack of striatal innervation. Although gene mutations in Netrin,
Slit2, Robo1, Dcc and Nrp255–59 also causes aberrant midline
crossing, these guidance cues are broadly expressed and their
tissue selective requirement has remained unclear. Our results
show for the first time that midline crossing of DA axons in the
hypothalamus is mediated by phenotypic alterations in the
Fig. 6 Impaired striatal axonal outgrowth and repulsion of DA axons by Nolz1−/− mutant striatum. a–d Dil injection in the striatum of E15.5 Wt and
Nolz1−/− mutant embryos. Images display the failure of striatonigral neurons to project to the midbrain in Nolz1−/− mutant embryos (a–b). c–d reduced
striatal axonal outgrowth in Nolz1−/− mutant mouse embryos. White arrows show the site of Dil injection. MB (midbrain). e Axon outgrowth from E13.5
Wt and Nolz1−/− mutant striatal explants in vitro. f Graph showing the percentage difference in axonal outgrowth from Nolz1−/− mutant striatal explants
compared with Wt. Mean ± standard deviation; n= 3 biologically independent experiments; Two-sided, unpaired T-test **p= 0.00475. g–h
Immunostaining of DARPP32 showing the lack of striatonigral projections in the hypothalamus of E14.5 Pcdh10−/− mutant embryos on coronal sections. i–j
Immunostaining of TH on coronal sections of the striatum of E14.5 Wt and Pcdh10−/− mutant embryos. k Striatal and midbrain explants obtained from Wt
and Nolz1−/− mutant embryos were cultured for 3 days and stained with b-TUBULIN (k) and TH (l). The proximal (P) part midbrain explant is facing the
striatal explant, while the distal (D) compartment is furthest away from it. m Quantification of the neurite length in both the proximal and distal
compartment of the explant culture assay as shown in (k). Graph shows P/D ratio. Mean values ± standard deviation; n= 4 biologically independent
experiments; Two-sided, unpaired T-test: Wt Striatum+Wt Midbrain versus Nolz1−/− Striatum+Wt Midbrain ***p= 0.000135; Wt Striatum+Wt
Midbrain versus Nolz1−/− Striatum+ Nolz1−/− Midbrain ***p= 0.00013; Wt Striatum+Nolz1−/− Midbrain versus Nolz1−/− Striatum+Wt Midbrain
**p = 0.00139; Wt Striatum+ Nolz1−/− Midbrain versus Nolz1−/− Striatum+ Nolz1−/− Midbrain **p= 0.00103. n Quantification of mean distance
between midbrain and striatum explants across all conditions. Mean values ± standard deviation; n= 5 biologically independent experiments. Data are
representative of three (a–e, g–j) or four (k) independent experiments. Scale bar 1000 μm (a–b), 500 μm (c–e, k, l), 200 μm (g–j). Hypo (hypothalamus)
and Str (Striatum). Source data are provided as a source data file.
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Fig. 7 Nolz1−/− mutant striatum repulses DA axons. a Schematic representation of scoring system. Red circles indicate collapsed growth cones.
Representative images of growth cones responses to control medium, E13.5 Wt and Nolz1−/− mutant-derived striatal conditioned medium, 50 ngml−1
TGFA, 300 ngml−1 NETRIN1 and 300 ngml−1 SEMA3A. b Graph showing the percentage of collapsed growth cones exposed to different conditions (n= 3
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medium versus SEMA3A medium ***p= 1.43231xE−05. c In situ hybridization showing expression of Egfr, Erbb4 and Nurr1 in E15.5 Wt ventral midbrain
(coronal sections). d–i Microfluidic assay to assess attractive and repulsive effects of Wt and Nolz1−/− mutant striatal tissue and TGFA signalling on DA
axons. Axons were labelled by b-TUBULIN. d Design of microfluidic platform. Primary DA neuronal cultures obtained from E13.5 Wt embryos were seeded
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mutant striatal explants with 50 ngml−1 TGFA (h) or Wt striatal explants with 50 nM Afatinib (i). j Graph showing the average axonal length of midbrain
neurons projecting out of the microgroove under different conditions Mean values ± standard deviation; n= 6 biologically independent experiments; Two-
sided, unpaired T-test: Wt Striatum versus Nolz1−/− Striatum ***p= 3.59072xE−06; Nolz1−/− Striatum versus Nolz1−/− Striatum+ TGFA **p= 0.0017;
Wt Striatum versus Wt Striatum+Afatinib ***p= 1.74752xE−06. Data are representative of three (a, c) or six (d–i) independent experiments. Scale bar
(a–i): 200 μm. Source data are provided as a source data file.
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striatum. Firstly, in Nolz1−/− mutant embryos gene expression
changes were only observed in the striatum, but not in other brain
regions DA axons are guided through. Secondly, the region
selective ablation of Nolz1 further confirmed that the misguidance
of DA axons is primarily a consequence of the absence of striatal
Nolz1 expression. Although FoxG1-IRES-Cre;Nolz1fl/fl condi-
tional mutant embryos display similar DA axon guidance defects
as observed in Nolz1−/− mutant embryos, the phenotype in the
conditional mutants is milder. In contrast to DA axons, the
importance of the striatum in the formation of forebrain axonal
tracts has been demonstrated before. For example, the shortening
of striatal axonal extensions in Celsr3−/− and Pcdh10−/− mutant
embryos36,60 impaired the establishment of thalamocortical
axonal projections. However, whether and how the specification
of striatal projection neurons influences the guidance and
innervation of DA axons has not been investigated in much
detail. While striatal defects observed in Nolz1−/− mutant
embryos totally abolished DA innervation, in other mutants with
striatal patterning defects the striatum remains innervated by DA
axons. For example, in Gsh1/2 double mutant embryos61 in which
striatal development is severely affected, DA terminals still enter
the striatum. Also, the striatum still receives DA axonal inner-
vation in Ebf1−/− and Rarb−/− mutant embryos in which the
specification of striatonigral neurons is impaired16,62,63. In
addition, while graded Netrin and Sema7a signalling in the
striatum are required for the topographic guidance of DA axons,
it is not necessary for DA innervation57,64. Thus, the loss of Nolz1
expression results in a striatal phenotype that uniquely affects the
guidance and innervation of DA axons. The striatonigral to
-pallidal lineage switch observed in Nolz1−/− mutant embryos
demonstrates the influence of striatal projection neuron subtype
specification on establishment of DA projections. Analysis of
Pcdh10−/− mutant embryos revealed that striatal axonal out-
growth is not required for directing DA projections towards
forebrain target areas. Therefore, it is more likely that the altered
composition of secreted factors emanated by Nolz1−/− mutant
striatum causes aberrant DA axonal tract formation and loss of
striatal innervation.
The striatum normally produces a permissive environment for
axonal tracts that are guided through the forebrain5,54,65.
However, extrinsic factors secreted from the Nolz1−/− mutant
striatum impose a repulsive effect on DA axons as shown by the
growth cone collapse assay and explant culture. Whether the
repulsive environment is caused by the loss of attractive or by the
induction of repulsive guidance factors in Nolz1−/− mutant
embryos will need to be determined. It is likely that a combina-
tion of factors secreted by the Nolz1−/− mutant striatum causes
the observed DA axon guidance phenotype. It has been shown
that axonal responsiveness to guidance factors is temporally
regulated and highly context dependent66. Also the induction
of cCASP3 in thalamic axons could alter axonal responsiveness to
extrinsic factors resulting in guidance defects67. We identified
TGFA as one of the secreted signalling molecules that is
downregulated in the striatum of Nolz1−/− mutant embryos. In
Tgfa−/− mutant embryos there is a slight reduction of striatal
innervation68. Interestingly, we showed that addition of TGFA
could rescue the outgrowth of DA axons towards the Nolz1−/−
mutant striatum. The TGFA receptors EGFR1 and ERBB4 are
expressed by DA neurons and blocking the receptor signalling by
Afatinib43 totally abolished the axonal outgrowth. So far, TGFA
signalling has been shown to regulate axonal growth indirectly
through its function in astrocytes69. Our finding suggests a more
direct role of this signalling pathway in regulating axonal growth
and shows that TGFA is sufficient to attract DA axons towards
the striatum. Detailed understanding of mechanisms involved in
the establishment of DA axonal projections will facilitate the
development of novel strategies to improve graft outcome in cell
replacement studies. Our study has identified several signalling
molecules altered in Nolz1 mutant striatum that could be further
exploited for its involvement in DA axon guidance. For example,
addition of signalling molecules including TGFA could promote
the outgrowth of DA axons from intranigral grafts and accelerate
target innervation.
Methods
Mouse lines. All mice were kept in standard conditions with food and water ad
libitum and maintained on the C57BL/6J genetic background. The Nolz1+/−
(Nolz1bgal/+) heterozygous mutant mouse line was generated by Brooks (manu-
script under preparation) in which the coding region of Nolz1 was replaced by the
beta-Galactosidase gene (Supplementary Fig. 1a). Nolz1fl/+ heterozygous mutant
mice were generated by Genoway by homologous recombination in mouse
d.
b.
Reduced striatal
outgrowth
c.
.
a.
Altered striatal secretion
Striatopallidal switch
d
c b
WT
Striatopallidal
Nolz1–/–
Nolz1–/–
WT
Nolz1–/–Mb
Midline crossing
WT
Nolz1–/–
Midline
a Repulsion
Attraction
Striatonigral
Striatopallidal
Str
WT
Str
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Nolz1−/− mutant striatum. The striatonigral–pallidal lineage switch causes (c) reduced striatal axonal outgrowth and (d) altered composition of growth
factors secreted from the striatum in the mutant embryos generating a repulsive environment for DA axons. The loss of attraction (d) causes DA axon
guidance phenotype as described in (a), while reduced axonal outgrowth alone has no impact on DA axons.
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embryonic stem (ES) cells. LoxP sites are flanking the coding region of exon 3
leaving the 3′UTR intact (Fig. 5a). The Neo cassette was removed by crossing
Nolz1fl/+ heterozygous mice with a Flp- recombinase expressing mouse line. The
Cre-mediated excision enables the deletion of the loxP-flanked region, resulting in
a Nolz1−/− knockout allele. The Cre deleter lines FoxD1Cre/+ (012463) and
En1Cre/+ (007916) were obtained from The Jackson Laboratory. The FoxG1-IRES-
Cre mouse line33 was obtained from Dr. Miyoshi (University of Tsukuba, Japan).
To obtain each individual conditional knockout line described in this study,
Nolz1fl/fl animals were crossed with either FoxG1-IRES-Cre/+;Nolz1fl/+, FoxD1Cre/+;
Nolz1fl/+, or En1Cre/+;Nolz1fl/+ animals to obtain FoxG1-IRES-Cre/+;Nolz1fl/fl,
FoxD1Cre/+;Nolz1fl/fl, or En1Cre/+;Nolz1fl/fl mutant offspring, respectively. The
following primers were used for genotyping: forward Nolz1 bGal (5′-
GTTGCAGTGACGGCAGATACACTTGCTGA-3′), reverse Nolz1 bGal (5′-
GCCACTGGTGTGGGCCATAATTCAATTCGC-3′), forward Annexin-1 (5′-
AGATGAAATTGGGTGCAAATTCTAAGGGG-3′), reverse Annexin-1 (5′-
TGTAAATATACTAGCTTCTGAGGAAGGCGACTTTG-3′), forward Cre (5′-
ATTGCTGTCACTTGGTCGTGGC-3′), reverse Cre (5′-GGAAAATGCTTC
TGTCCGTTTGC-3′). Forward and reverse Annexin-1 primers were designed and
validated by GenOway for the specific detection of the conditional knockout allele in
Nolz1fl/fl conditional knockout mouse lines. The Pcdh10+/− heterozygous mouse
line36 was bred by Dr. Ferri (University of Iowa, USA) and used to obtain Pcdh10−/−
mutant embryos. All animals were kept on a 12 h day/night cycle, at 50 ± 10%
humidity and at 21 ± 1 °C. All animal procedures followed the guidelines and leg-
islation as regulated under the Animals Scientific Procedures Act 1986 (ASPA) and
were approved by the Animal Welfare and Ethical Review Body (AWERB) from the
University of Leicester.
Immunohistochemistry. Embryonic tissue was fixed in 4% PFA on ice for either
1 h (E11.5 heads), 1.5 h (E13.5 heads and E15.5 brains) or 3 h (E18.5 dissected
brains). Brains were embedded in OCT (VWR) and cryosectioned at a thickness of
12 μm using a Leica cryostat CM3050S. Sections were mounted on Superfrost plus
glass slides (Thermo Scientific, USA) and air dried for 30 min and washed 3 × 5
min in PBS/0.1% triton-x. Adult brains were fixed in 4% PFA overnight at 4 °C and
sections were cut on a freezing microtome (Leica) at a thickness of 30 μm.
Immunohistochemistry was performed as described18. Nuclei were visualized by
DAPI (Sigma). Stained cells were analyzed using a confocal microscope (LSM 510
Meta, Zeiss or LSM 880, Zeiss). The antibodies and concentrations are shown in
the supplementary resource table.
BrdU administration and tissue processing. Time-mated pregnant females were
injected subcutaneously with 5-bromo-2′-deoxyuridine (BrdU) 100 mg kg−1
(Sigma Aldrich, USA) at E10.5, E11.5 or E12.5. Embryos were isolated at E15.5 and
dissected brain were fixed for 1.5 h in 4% PFA on ice and further processed as for
immunohistochemistry. For BrdU staining, sections were incubated with 0.1 M
citric acid for 20 min at 100 °C, adjusted to room temperature and rinsed three
times in PBS before applying the blocking solution containing 0.25% Triton X-100
(Sigma), 5% donkey serum in PBS (Jackson ImmunoResearch, UK). Sections were
incubated with rat monoclonal anti-BrdU antibody (1:500, Abcam) diluted in
blocking solution at overnight at 4 °C. The next day, sections were washed three
times in PBS before being incubated for 1 h with a goat anti-rat secondary antibody
(1:500, Abcam).
In situ hybridization. Tissue was fixed and processed as described for the
immunohistochemistry. Probes were selected from gene lists obtained by com-
paring gene expression profiles of E18.5 Wt and Nolz1−/− mutant striatum. Pri-
mers used for generating in situ probes are shown in the supplementary Table 3.
The in situ probes were produced by in vitro transcription as using cDNA from
E18.5 mouse embryos as a template. The in situ hybridization was performed
following standard procedures. Sections were analyzed and photographed using
Axiovert 200 microscope (Zeiss) equipped with a digital camera using 10x
magnification.
In vitro explant culture in collagen matrices. Ventral midbrain, striatal and
thalamic explants were obtained from E13.5 embryos as described40. Striatal
explants were embedded in a collagen matrix either with an explant derived from
the ventral midbrain or thalamus as previously described40 with some minor
modifications. Special care was taken to keep a distance of 300–500 μm (1 explant
size) between explants during the embedding process. Explants were cultured in
explant medium containing Neurobasal A medium supplemented with B27, 1 M
Hepes, L-glutamine, Pen-Strep and Beta-mercaptoethanol for 3 days. To determine
the attractive/repulsive effects on midbrain and thamamic explants, the length of b-
Tubulin labelled axons was measured with Zeiss software 2012. For quantification,
the midbrain and thalamic explants were divided into two areas, proximal (facing
towards the explant) and distal (facing away from explant). In cases where explants
extended many axons, only the five largest were considered. The average axonal
length for the proximal and distal compartments was calculated to obtain the P/D
ratio. When the value was >1.0, the effect was considered attractive; values <1.0
were considered to be indicative of a repulsive effect40. The distance between two
explants was measured using the Measure function in Zeiss software 2012 to
control for aberrant distance-mediated effects on axonal outgrowth.
Axonal growth chambers in microfluidic devices. Polydimethylsiloxane micro-
fluidic devices were purchased from Xona Microfluidics (Standard Neuron Device
Cat.No: SND900) and were used according to the manufacturer’s protocol. Briefly,
they were attached by pressure to a 10 cm dish precoated with poly-D-lysine (50 μg
mL−1). Wt ventral Midbrain tissue was dissected from E13.5 mouse embryos, kept
in 5% FCS+DMEM solution and dissociated with TrypLE Express (Gibco) to
obtain a single-cell suspension of DA neurons. Cells were then plated (50,000 cells
μL−1) in the cell compartment of the microfluidic device. After 10 min, 150 μL of
explant medium was added. The other side of the chamber was filled with 200 μL of
explant medium with striatum explants from Wt (positive control) or Nolz1−/−
mutant embryos. Nolz1−/− mutant striatal tissue was treated with 50 ng ml−1
TGFa, while 50 nM Afatinib was added to wild-type striatal explants. Afatinib was
dissolved in DMSO at a stock concentration of 100 mM and diluted to 50 nM using
serial dilutions. DMSO was added to wild-type striatal explants as a control at a
similar concentration. Devices were then maintained at 37 °C in humidified 5%
CO2/95% air for 9 days and medium was changed regularly every 2–3 days. Cells
were fixed by adding 200 μl of pre-warmed 4% PFA with 10% sucrose and stored at
4 °C for immunohistochemistry. Importantly, while cells were seeded at the same
initial density, each chamber contained a variable number of axons after 9 days.
Axonal length in the devices was measured using Zeiss ZEN black 2012 software by
drawing a segmented line along each individual axon projecting out of the
microgroove in the distal compartment.
Dil injection. Tracing of neural projection with DiI (1,1-dioctadecyl-3,3,3,3-tet-
ramethyl-indocarbocyanine perchlorate; Molecular Probes) was done as descri-
bed36. For labelling axonal striatal projections, we microinjected a DiL solution
(100 μg ml−1 in N,N-dimethylformamide) using microcapillare pressure into the
striatum on fixed E15.5 mouse brains. Brain injected were then incubated in 4%
PFA in rotation during 4 weeks at RT. The brains were then sectioned by vibra-
tome (Leica VT1200S) (150-μm section) and analyse directly by confocal
microscope.
Striatal conditioned medium. The striatum was dissected from E13.5 mouse
embryos in 5% FCS+DMEM solution and dissociated with TrypLE Express
(Gibco) to obtain single cells DA neurons. Cells were plated (1 striatum/well) in 24
wells plate coated with poly-D-lysine (50 μg mL−1). One millilitre of explant
medium previously describe was added. Striatal conditioned medium was obtained
after 7 days of striatal primary culture from striatum Wt or Nolz1−/− mutant. The
media were collected and immediately placed on dry ice and then stored at −80 °C.
Growth cone collapse assay. Wells were coated overnight with poly-D-lysine (50
μg mL−1, Sigma) at 4 °C, subsequently washed with sterile PBS three times before
being coated with laminin (1:10 in PBS, Invitrogen, UK) and incubated for 2 h at
37 °C. In the meantime, ventral midbrain tissue was dissected from E13.5 WT
mouse embryos, placed in ice-cold, Dulbecco’s modified Eagle’s medium (DMEM;
Gibco-BRL), sectioned into small pieces and then placed into the centre of each
laminin-coated well. Before seeding, wells were washed two times with sterile PBS
and then supplemented with explant medium as previously described40. Explants
were then cultured at 37 °C for 72 h to the laminin-coated wells. For control
experiments, the explant medium was removed and replaced with fresh medium.
Either conditioned medium derived from Wt and Nolz1−/− mutant striatal tissue
or recombinant proteins (R&D) of the axon guidance cues NETRIN1, SEMA3A
and TGFa were added to the cell medium at a concentration of 300 ng mL−1,
300 ng mL−1 and 50 ng mL−1, respectively. Following addition of appropriate
medium or recombinant protein, plates were incubated at 37 °C for 30 min. After
the fixation (1 h in pre-warmed 4% PFA with 10% sucrose), explants were washed
with PBS and stored at 4 °C. For quantification, growth cones were scored as either
collapsed or uncollapsed using an inverted phase contrast microscope with a ×40
objective. According to previous published methods41, tips of axons were classified
as uncollapsed if prominently spread growth cones with flattened lamellipodia and/
or two or more filopodia were identified. Bullet-shaped neurite tips with less than
two filopodia and/or no lamellipodium present were scored as collapsed
growth cones.
Image acquisition and quantification. Images were acquired on an Axiovert 200
M inverted microscope, Zeiss LSM 880 or Zeiss LSM 510 confocal microscopes and
captured at ×10, ×20 or ×25 objective depending on staining procedure, sample size
and area of interest. Images were processed using Adobe Photoshop CC2018 and
Adobe Illustrator CC2018 software. For quantification, high-definition tilescan
confocal images were taken at each level of the striatum in three different animals
per condition using the lateral ventricle as an anatomical landmark. Images were
opened with ImageJ and converted to 8-bit. Positively labelled cells were identified
using built-in threshold algorithms to best determine the intensity of the back-
ground against the positive staining. After applying the threshold settings, a spe-
cified region of interest was traced along the contours of the striatum and positively
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labelled cells were quantified semi-automatically in ImageJ. Similarly, to quantify
the total area of each striatum, the striatum was manually delineated in each single-
plane section using the line selection tool and the total area was automatically
computed across all rostro-caudal sections of the striatum. Results were converted
from pixels2 to mm2 by spatially recalibrating each image. Microsoft Excel was
used for the organization and statistical analysis of the data.
Cell counting and fibre density analysis. To determine the percentage of
Aldh1a1 expressing TH neurons in the midbrain the number of ALDH1A1 and TH
positive cells was counted manually in every 4th section of each E18.5 embryo in at
least three embryos of each genotype. Statistical significance was calculated by the
unpaired student’s t test and data is presented as mean ± sd. Striatal fibre density of
GlycoDAT positively labelled axonal projections was measured by densitometry
using ImageJ software. Striatal sections were fluorescently labelled with GlycoDAT
and images were taken using confocal microscopy. Fibre density of whole striatal
area was measured and the measured values were corrected for non-specific
background staining by subtracting values obtained from the cortex. Of each
embryo every 8th section was analyzed of at least three different embryos.
iDISCO. Dissected brains from E18.5 WT and Nolz1−/− mutant embryos were
processed as previously described22. Briefly, whole brains were dehydrated in
methanol in PBS and bleached overnight at 4 °C. Tissue was then gradually
rehydrated in PBS by removing. Detergent washing was then performed in PBS
with 0.2% Triton X-100 (2 × 1 hr). Tissue was incubated overnight at 37 °C in PBS
with 0.2% Triton X-100 and 0.3 M glycine, followed by blocking in PBS with 0.2%
Triton X-100 and 6% normal donkey serum for 2 days. Following blocking, the
tissue was washed for 1 hr twice in PBS with 0.2% Tween-20 and 10 μg mL−1
heparin (PTwH). Brains were incubated with a primary rabbit-anti-TH (1:400)
antibody diluted in PTwH/5%DMSO/3% Donkey serum at 37 °C for 4 days. Excess
primary antibody was washed for 1 day in PTwH with periodic solution changes.
Secondary antibody donkey anti rabbit Alexa 647 (1/250) was applied in PTwH/3%
Donkey serum at 37 °C for 4 days. After incubation with the secondary antibody,
samples were washed in PTwH for 5 days with periodic solution changes. After
washing away excess secondary antibodies, optical clearing of iDISCO samples was
performed as described in ref. 22. Tissue was gradually dehydrated in resistant
glassware with tetrahydrofuran in water. Remaining lipids were extracted with
dichloromethane for 1 hr and dibenzyl ether (DBE) was used for refractive index
matching. Samples were kept in a full vial of DBE.
3D imaging. E18.5 Wt and Nolz1−/−mutant brain tissue were imaged in horizontal
orientation with an Ultramicroscope II (LaVision BioTec) lightsheet microscope
equipped an MVX-10 Zoom Body (Olympus), MVPLAPO ×2 Objective lens
(Olympus), Neo sCMOS camera (Andor) (2560 × 2160 pixels. Pixel size: 6.5 × 6.5
µm2) and Imspector (version 5.0285.0) software (LaVision BioTec). Samples were
scanned with double sided illumination, a sheet NA of 0.148348 (results in a 5-µm-
thick sheet) and a step-size of 2.5 µm using the horizontal focusing light sheet
scanning method with the optimal amount of steps and using the contrast blending
algorithm. The effective magnification for all images was 4304× (zoombody ×
objective+ dipping lens= 2× × 2.152×). Following laser/filter combination was
used: Coherent OBIS 647-120 LX laser with a 676/29 emission filter.
RNA extraction and quantitative real-time PCR. Total RNA was extracted using
a RNeasy micro kit (Qiagen) according to the manufacturers’ protocols. Biological
replicates were obtained from at least three independent experiments. The RNA
quality was assessed using a Nanodrop 2000 spectrophotometer (Thermo Scien-
tific) prior to amplification. cDNA was synthesized from total RNA via reverse
transcription using the reverse transcriptase SuperScriptIII (Invitrogen) and Oli-
godT as primer (Invitrogen). Real-time qPCR was performed on a QuantStudio 6
Flex system (Thermo Fisher) using Fast SYBR Green Mastermix (Thermo Fisher).
Gene expression values were normalized against RPL19 and fold change was cal-
culated using the 2−ΔΔCT method. The primer sequences used are shown in the
supplementary resource table. Measurement were taken from distinct samples.
Significance was determined by the two-tailed student’s t test.
RNA sequencing and bioinformatic analysis. Striatal tissue was dissected from
both hemispheres of E18.5 Wt and Nolz1−/− mutant embryos, frozen on dry ice
and stored at −80 °C. Each sample containing both hemispheres from the same
embryos was further processed for RNA extraction using RNeasy Micro Kit
(Qiagen Inc., UK). Three replicates consisting both hemispheres were used for each
biological condition.
Library preparation. Total RNA was first examined using the Agilent RNA 6000
Nano kit. All samples passed QC with a RIN value > 8. To remove ribosomal RNA
2.5 μg total RNA was treated with the Illumina RiboZero Gold (Human/Mouse/Rat)
kit, according to the manufacturer’s protocol. From 100–200 ng of the ribo-depleted
RNA sequencing libraries were prepared using the Illumina TruSeq Stranded
mRNA kit, according to the manufacturer’s protocol. Sequencing libraries were
examined using the Agilent High Sensitivity DNA kit, and library concentrations
determined. Sequencing was carried out by the Earlham Institute, 150PE using the
HiSeq4000. Sequenced libraries were verified using FastQC (version 0.11.5).
RNA-seq data analysis. Adapters were trimmed using Cutadapt (version 1.16).
Reads were mapped to the genome in a transcriptome-aware manner using
HISAT2 (version 2.1.0), using the mouse HISAT2 genome tran index (Ensembl,
GRCm38). Features were counted using the featureCounts function from the
Rsubread package (version 1.28.1), using the annotation in the relevant Ensembl gtf
file (GRCm38 release 92).
Bioinformatics. The differential expression between WT and mutant was analyzed
using the DESeq2 (version 1.18.1) package. Genes were identified as being differ-
entially expressed at an adjusted p value of <0.05 for the DESeq2 results and with a
fold change of at least 1.5. Genes passing these thresholds, in either method, were
used in subsequent analyses. Using these criteria there were 166 genes down-
regulated and 139 genes upregulated in the Nolz1−/− mutant striatum. The
heatmap was created using the heatmap.2 function within the gplots R package
using significantly changing genes from the DESeq2 analysis with a fold change of
at least 2. Clustering was done within heatmap.2 using complete-linkage.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The transcriptomic data have been deposited to ArrayExpress with the data set identifier
E-MTAB-8240 (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-8240/). All
data are included in this article and supplemental data files and are available from the
corresponding author upon reasonable request. The source data underlying Figs. 2u, v, w;
3f; 4c, d, e; 5g; 6f, m, n; 7b, j and Supplementary Figs. 1d, e; 2c; 4b, c, g; 8c can be found in
the source data file.
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